Federal contract award
75N98026P00014
SINGLE CELL WHOLE GENOME SEQUENCING IN PERIPHERAL BLOOD OF PATIENTS WITH VEXAS SYNDROME
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH OLAO |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | 6640 — Laboratory Equipment and Supplies |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $29.0K |
| Current contract value | $29.0K |
| Potential contract value / ceiling | $29.0K |
| Start date | Feb 23, 2026 |
| Current end date | Jun 10, 2026 |
| Potential end date | Jun 10, 2026 |
| Latest award activity | Feb 19, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Feb 19, 2026 | 0 | $29.0K | SINGLE CELL WHOLE GENOME SEQUENCING IN PERIPHERAL BLOOD OF PATIENTS WITH VEXAS SYNDROME |
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| BURKETT, Roxane | Contact | burkettr@nhlbi.nih.gov +1 301 435 6671 | Source | Jan 28, 2026 |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.